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Abstract
G protein-coupled receptors (GPCRs) are a superfamily of integral membrane proteins vital for signaling and are important
targets for pharmaceutical intervention in humans. Previously, we identified a group of ten amino acid positions (called key
positions), within the seven transmembrane domain (7TM) interhelical region, which had high mutual information with each
other and many other positions in the 7TM. Here, we estimated the evolutionary selection pressure at those key positions.
We found that the key positions of receptors for small molecule natural ligands were under strong negative selection.
Receptors naturally activated by lipids had weaker negative selection in general when compared to small molecule-
activated receptors. Selection pressure varied widely in peptide-activated receptors. We used this observation to predict
that a subgroup of orphan GPCRs not under strong selection may not possess a natural small-molecule ligand. In the
subgroup of MRGX1-type GPCRs, we identified a key position, along with two non-key positions, under statistically
significant positive selection.
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Introduction
G protein-coupled receptors (GPCRs) constitute a diverse
superfamily of integral membrane proteins involved in intercellu-
lar signal transduction. Their genes are expressed in almost all
eukaryotes [1,2,3,4,5]. The receptor consists of a single polypep-
tide chain that loops through the cell membrane seven times to
form an interhelical cavity of seven alpha-helical transmembrane
domains (7TMs). GPCRs are the largest superfamily of integral
membrane proteins in humans. About half of the GPCRs in the
human genome are non-olfactory receptors [6,7,8]. These
receptors mediate vital physiological functions and are a major
target for pharmaceutical interventions [9,10]. Although diverse in
sequence composition and function, GPCRs share a common
molecular architecture of 7TMs connected via three intracellular
and three extracellular loops. Fredriksson and Schioth have
categorized the GPCRs into five distinct families [8,11] -
Glutamate (also known as class C), Rhodopsin (also known as
class A), Adhesion, Secretin (collectively known as class B) and
Frizzled/Taste (also known as class F). Nearly 85% of the non-
olfactory receptors belong to class A. Class A receptors bind
different natural ligands that range from small-molecules such as
ADP to larger ones such as neuropeptides or chemokines.
New protein functions in paralogous protein superfamilies arise
by the modulation of older existing ones [12]. During this
evolutionary process, some of the amino acid residues remain
conserved. However, mutations of some residues may be followed
by compensatory mutations elsewhere to preserve function or give
rise to new ones. The identification of such related residue
positions can help to identify biologically relevant sets of residues
in protein superfamilies. Previously, we identified a set of positions
in the interhelical cavity enclosed within the 7TM domain of class
A GPCRs that have high mutual information (MI) with other
positions and each other [13,14]. These key positions were found
to be located in the region that constitutes the binding cavity of
GPCRs whose structures have been solved. Biochemical data
suggest that this region hosts the orthosteric binding cavity for all
class A GPCRs naturally activated by small molecules.
Here, we examine the nucleotide sequences corresponding to
these GPCRs to probe the evolutionary selection pressure at these
key positions. Synonymous nucleotide substitutions (‘silent’
mutations) do not change the translated amino acid sequence so
their substitution rate dS (also referred to as KS) is not subject to
selective pressure on the expressed protein. Nonsynonymous
mutations alter the amino acid sequence and their substitution rate
dN (also referred to as KA) is a function of selective pressure on the
protein. The ratio dN/dS,, referred to as v, gives a measure of the
selection pressure at that site [15,16]. When there exists negative
or purifying selection pressure at a codon position, v,1 and
synonymous substitutions dominate. When the position is under
positive or adaptive selection, v.1 and nonsynonymous substitu-
tions dominate. Rare instances of positive selection are of special
interest in tracing functional divergence among protein families
and physiological adaptations in humans [17,18,19,20,21]. When
the position evolves neutrally – without any strong preferential
selection, the two substitution rates are nearly equal. Here we
determine v at the key positions and compare it to other 7TM
positions. If the selection pressure at the key positions is less neutral
then on other positions then this supports the hypothesis that the
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Subgrp idx # GPCRs in subgrp GPCRs included in the subgroups
a Natural ligand
Chemical class of
natural ligand
b Notes
c
1 5 CHRM1 (ACM1), CHRM2 (ACM2),
CHRM3 (ACM3), CHRM4 (ACM4),
CHRM5 (ACM5)
acetylcholine small
2 5 DRD1, DRD2, DRD3, DRD4, DRD5 dopamine small
3 5 P2RY12 (P2Y12), P2RY13 (P2Y13),
P2RY14 (P2Y14), GPR87, GPR171
(GP171)
nucleotides, lysophosphatidic acid
(GPR87)
small o, S
4 7 HTR1A (5HT1A), HTR1B (5HT1B),
HTR1D (5HT1D), 5HT1F (HTR1F),
HTR1E (5HT1E), HTR5A (5HT5A),
HTR7 (5HT7R)
5-hydroxytryptamine small
5 5 P2RY1, P2RY2, P2RY4, P2RY6,
P2RY11 (P2Y11)
nucleotides small
6 3 MTNR1A (MTR1A), MTNR1B (MTR1B),
GPR50 (MTR1L)
melatonin small o
7 5 ADRA1A (ADA1A), ADRA1B (ADA1B),
ADRB1, ADRB2, ADRB3
Adrenaline small
8 3 HTR2A (5HT2A), HTR2B (5HT2B),
HTR2C (5HT2C)
5-hydroxytryptamine small
9 4 HRH1, HRH2, HRH3, HRH4 Histamine small
10 3 ADORA1 (AA1R), ADORA2A (AA2AR),
ADORA2B (AA2BR)
Adenosine small
aThe receptors are indicated through their gene name. Uniprot name, when different from the gene name, and common synonyms are listed in parentheses. Orphan
receptors are indicated in bold and indicated as ‘o’ in Notes.
bSmall indicates ‘‘small molecules’’ and refers to biogenic amines, nucleosides and nucleotides.
cThe symbol ‘‘o’’ indicates that the subgroup has one or more orphan GPCR.
doi:10.1371/journal.pone.0027813.t001
Table 2. List of class A GPCRs included in the study (continued from Table 1).
Subgrp idx
# GPCRs
in subgrp
GPCRs included in the
subgroups
a Natural ligand
Chemical class of
natural ligand Notes
c
11 6 S1PR2 (EDG5), S1PR1 (EDG1), S1PR3 (EDG3),
S1PR5 (EDG8), LPAR1 (EDG2), LPAR3 (EDG7)
sphingosine 1-phosphate,
lysophosphatidic acid (LPAR1, LPAR3)
lipid
12 3 GPR3, GPR6, GPR12 sphingosine 1-phosphate lipid
13 3 FFAR1 (GPR40), FFAR2 (GPR43),
FFAR3 (GPR41)
free fatty acids lipid
14 7 PTGDR (PD2R), PTGER1 (PE2R1),
PTGER3 (PE2R3), PTGER4 (PE2R4),
PTGFR (PF2R), PTGIR (PI2R), TBXA2R (TA2R)
prostaglandins,
thromboxane (TA2R)
lipid
15 3 CYSLTR1 (CLTR1), CYSLTR2(CLTR2), GPR17 cysteinyl leukotrienes lipid
13b
d 4 FFAR1 (GPR40), FFAR2 (GPR43),
FFAR3 (GPR41), GPR42 (pseudogene)
free fatty acids lipid
16 5 LPAR4 (P2RY9), LPAR6 (P2RY5),
GPR174 (GP174), P2RY10 (P2Y10),
PTAFR
lysophosphatidic acid,
sphingosine 1-phosphate (P2Y10),
platelet activating factor
lipid o
17 5 RRH (OPSX), OPN3, OPN4, OPN5, RGR Retinoids lipid
18 4 OPN1MW (OPSG), OPN1LW (OPSR),
RHO (OPSD), OPN1SW (OPSB)
Retinoids lipid
19 3 GPR81, GPR109B (G109B),
GPR109A (G109A)
hydroxylated short and
medium-chain fatty acids
lipid
aThe receptors are indicated through their gene name. Uniprot name, when different from the gene name, and common synonyms are listed in parentheses. Orphan
receptors are indicated in bold and indicated as ‘o’ in Notes.
cThe symbol ‘‘o’’ indicates that the subgroup has one or more orphan GPCR.
dDerived from subgroup 13 through the addition of the pseudogene GPR42.
doi:10.1371/journal.pone.0027813.t002
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high entropy did not simply arise from evolutionary drift.
Results
All subgroups of human GPCRs were classified into three
categories in terms of their natural ligands: 1) small molecules
(including biogenic amines, nucleosides and nucleotides), 2) lipids,
and 3) peptides. GPCR subgroups whose natural ligands could not
be exclusively classified as any of the above were categorized as
divergent. A number of human GPCRs are orphans with no known
natural ligands. The list of GPCR subgroups and the chemical class
of associated natural ligands is in Tables 1, 2, 3 and 4. Of the 45
subgroups of GPCRs, excluding subgroup 13b, 10 subgroups are
activated by small molecules listed in Table 1, 9 subgroups are
activated by lipids listed in Table 2, and 19 subgroups are activated
by peptides listed in Table 3. Six subgroups were categorized as
divergent, because they are activated by natural ligands that belong
to different chemical classes or contain two or more orphans. One
subgroup exclusively contained human orphan GPCRs. The
divergent and orphan subgroups are listed in Table 4.
The v values were determined for subgroups with at least three
paralogs. Selection pressure at the key positions, vkey, is shown in
Figure 1. The vkey and its average, ,vkey., of subgroups associated
with small molecules differed from that of subgroups associated with
lipids and peptides. The Kruskal-Wallis rank sum test showed that
,vkey. for small molecule-activated receptors had significantly
lower values compared to subgroups of lipid-activated receptors,
peptide-activated receptors and divergent receptors (p,0.003). The
vkey values from all ten subgroups activated by small molecules
showed strong negative selection (v,0.05).
We confirmed that human MRGX1-type receptors are under
positive selection [22,23]. Positive selection at three positions was
inferred in subgroup 38 (MRGX1, MRGX2, MRGX3 and
MRGX4 pain receptors) using three different tests. The results of
the likelihood ratio estimates are shown in Table 5. The results of
v for key positions and positions with posterior probability of
positive selection exceeding 0.5 are shown in Table 6. We inferred
strong positive selection at key position 3.29 in the Ballesteros-
Weinstein scheme [24], (v=6.3, posterior probability for
v.1=0.998). Two non-key positions: 2.56 (v=6.1, posterior
probability for v.1=0.948) and 2.60 (v=6.1, posterior proba-
bility for v.1=0.947) were also under positive selection. Six of
the key positions (5.35, 3.33, 5.42, 6.55, 7.35 and 7.39) were not
under statistically significant positive selection. Three key positions
(3.32, 4.60 and 5.39) were under negative selection. Subgroup 41
(MAS1L, MRGRD, MAS, and MRGRF pain receptors) did not
show any statistically significant signature for positive selection.
Previous studies had demonstrated positive selection pressure for
the combined subgroups 41 and 38 (MRG receptors from humans
Table 3. List of class A GPCRs included in the study (continued from Tables 1, 2).
Subgrp idx
# GPCRs in
subgrp GPCRs included in the subgroups
a Natural ligand
Chemical class of
natural ligand
b Notes
c
20 3 TACR1 (NK1R), TACR1 (NK2R), TACR3 (NK3R) tachykinin neuropeptides peptide
21 3 TSHR, LHCGR (LSHR), FSHR glycoprotein hormones peptide
22 4 F2R (PAR1), F2RL1 (PAR2), F2RL2 (PAR3),
F2RL3 (PAR4)
unmasked N-terminus peptide
23 5 GPR83, NPY1R, NPY2R, PPYR1 (NPY4R), NPY5R neuropeptide Y and peptide YY peptide o
24 3 C3AR1 (C3AR), C5AR1 (C5AR), GPR77 (C5ARL) anaphylatoxins peptide
25 4 EDNRA, EDNRB, GPR37, GPR37L1 (ETBR2) Endothelins peptide o
26 5 LGR5, LGR6, RXFP1 (LGR7), RXFP2 (LGR8) Relaxin peptide
27 3 GALR1, GALR2, GALR3 Galanin peptide N
28 4 OPRL1 (OPRX), OPRM1 (OPRM),
OPRD1 (OPRD), OPRK1 (OPRK)
opioid peptides peptide N
29 3 SSTR2 (SSR2), SSTR3 (SSR3), SSTR5 (SSR5) somatostatins peptide
30 3 GRPR, NMBR, BRS3 bombesin-related peptides peptide
31 3 MC3R, MC4R, MC5R melanocortins peptide N
32 3 AVPR1A (V1AR), AVPR1B (V1BR), AVPR2 (V2R) Vasopressin peptide N
33 10 CXCR1, CXCR2, CXCR3, CXCR4, CXCR5,
CXCR6, CCR6, CCR7, CCR9, CCR10
Chemokines peptide
34 5 APLNR (APJ), AGTR1 (AG2R, AG2S),
RL3R1 (RLN3R2), RXFP4 (RLN3R2)
apelin (APLNR), angiotensin
(AGTR1), relaxin (RL3R1, RLN3R2)
peptide
35 3 NTSR1 (NTR1), NTSR2 (NTR2), GPR39 neurotensin, obestatin (GPR39) peptide
36 9 CCR1, CCR2, CCR3, CCR4, CCR5, CCR8,
CCRL2, CX3CR1(CX3CR1, C3X1), CCBP2
Chemokines peptide S
37 3 FPR1, FPR2 (FPRL1), FPR3 (FPRL2) N-formyl-methionyl peptides (FPRs) peptide
38 4 MRGPRX1 (MRGX1), MRGPRX2 (MRGX2),
MRGPRX3 (MRGX3), MRGPRX4 (MRGX4)
enkephalins (MRGPRX1),
cortistatins (MRGPRX2)
peptide o
aThe receptors are indicated through their gene name. Uniprot name, when different from the gene name, and common synonyms are listed in parentheses. Orphan
receptors are indicated in bold and indicated as ‘o’ in Notes.
cThe Symbol ‘‘N’’ indicates that pairs of receptors of the subgroup do not satisfy max(dN),1 in the Nei-Gojobori counting scheme [64]. The symbol ‘‘S’’ indicates that
pairs of receptors from the subgroup do not satisfy max (dS),3 in the Nei-Gojobori scheme. The symbol ‘‘o’’ indicates that the subgroup has one or more orphan GPCR.
doi:10.1371/journal.pone.0027813.t003
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subgroup, 44, also exhibited positive selection exclusively within
7TMs but subgroup 41 did not exclusively exhibit statistically
significant positive selection. Results from the likelihood ratio test
for subgroup 44 are included in Table 5. An independent analysis
of subgroup 44 confirmed statistically significant positive selection
at key positions 3.29 and 5.35 along with two non-key positions
2.57 and 2.60. (Position 2.60 showed positive selection in subgroup
38 but not position 2.57).
We next compared ,vkey. to random sets of 7TM positions
,vrandom7TM. to see if there was stronger selection pressure at
the key positions. The values are shown in Figure 2 and Figure S1.
For most receptor subgroups binding to small molecules, ,vkey.
was less than ,vrandom7TM. although within two standard
deviations of ,vrandom7TM.. The selection pressure for subgroup
42 was atypical in that ,vkey. was larger than ,vrandom7TM. by
two standard deviations. For six of nine subgroups associated with
lipid-activated receptors, ,vkey. was nearly equal to ,vran-
dom7TM.. In subgroups activated by peptides, ,vkey. was less
than or nearly equal to ,vrandom7TM.. Subgroup 38, which
exhibits strong positive selection, was the only other case where
,vkey. exceeded ,vrandom7TM. by two standard deviations.
Linear regression of ,vkey. vs. ,vrandom7TM. for the subgroups
excluding subgroup 38 and 44, showed a linear dependence
(R
2=0.892, p,2.2610
216) (See Figure S2). However, as seen in
Figure 3, ,vkey./,vrandom7TM. is less than unity for small
,vkey. and increases significantly with ,vkey. (p,3.6610
26)
and ,vrandom7TM. (p,4.9610
23). The dependence remained
significant even after including subgroup 38. The Yang and
Swanson’s ‘‘fixed sites’’ model [25] indicated that ,vkey. was
significantly lower than ,vrandom7TM. in two of the ten small
molecule subgroups (subgroups 3 and 10). Subgroup 11, which
consists of lipid-activated receptors, showed statistically significant
differences between key and random positions. In 5 of the 19
subgroups of the peptide receptors, key positions have significantly
higher selection pressure then random positions. Only subgroup
22 of the peptide-activated receptors was significantly lower. The
results are summarized in Table S1.
We also tested if the diversity of vkey values in subgroups was
due to the dissimilarity among amino acid (AA) residues at a given
MSA position since it is expected that stronger selection pressure
should result in lower variability. However, the strength of the
correlation between vkey and variability was not known. We
examined this with three different measures. First, we computed
the Shannon entropy (H) for the key positions of each subgroup,
which has a theoretical range of 0 bits#H#4.32 bits. Figure S3
shows H for every key position across all subgroups. Figure S4 is a
plot of H vs. ,vkey. for subgroups with average pair-wise
max(dN),1 (see Materials and Methods). This figure shows a slight
trend of higher entropy for higher ,vkey. although it was not
statistically significant. A linear regression of ,Hkey. against
log10,vkey. found a correlation coefficient of R=0.47
(p,1.4610
23). However, the regression of ,Hkey. against log10
,vkey. had much lower correlation when ,vkey. was restricted
to ,vkey., 0.1 (R=0.26, p,9.8610
22). However, this decrease
in correlation could be due to the decrease in statistical power
because the sample size is reduced. Similar results were found
using the BLOSUM80 substitution matrix [26] and a distance
matrix Dkey to estimate the dissimilarity among residues within
subgroups at key positions. Results are in Figures S5, S6, S7, and
S8. These results show that AA variability at MSA positions is only
weakly correlated with ,vkey. and the correlation is weaker for
subgroups under strong negative selection.
Table 4. List of class A GPCRs included in the study (continued from Tables 1, 2 and 3).
Subgrp idx
# GPCRs in
subgrp GPCRs included in the subgroups
a Natural ligand
Chemical class of
natural ligand
b Notes
c
39
e 5 GPR101 (GP101), GPR161 (GP161),
GPR135 (GP135), GPR63, GPR45
sphingosine 1-phosphate divergent o
40 3 GPR4, GPR65 (PSYR), GPR68 (OGR1) protons (GPR4 and GPR68),
glycosphingolipids (GPR65)
divergent N
41 4 MAS1 (MAS), MAS1L (MRG), MRGPRD
(MRGRD), MRGPRF (MRGRF, GPR140)
angiotensin (MAS1),
b-alanine (MRGRD)
divergent o
42
e 5 TAAR1 (TAR01), TAAR5, TAAR6 (TAR4),
TAAR8 (TAR5), TAAR9 (TAR3)
trace amines divergent o,S
43
g 10 C3AR1 (C3AR), C5AR1 (C5AR), GPR77
(C5ARL), CMKLR1(CML1), FPR1,
FPR2 (FPRL1), FPR3 (FPRL2),
GPR1, GPR32, GPR44 (CRTH2)
Anaphylatoxins (C3AR1, C5AR1,
GPR77), chemokines (CMKLR1),
N-formyl-methionyl peptides (FPRs),
chemerin (GPR1), resolvins (GPR32),
prostanoids (GPR44)
divergent
44
f 8 MAS1 (MAS), MAS1L (MRG), MRGPRD
(MRGRD), MRGPRF (MRGRF, GPR140),
MRGPRX1 (MRGX1), MRGPRX2 (MRGX2),
MRGPRX3 (MRGX3), MRGPRX4 (MRGX4)
angiotensin (MAS1),
b-alanine (MRGRD), enkephalins
(MRGPRX1), cortistatins (MRGPRX2)
divergent o
45 3 GPR27, GPR85, GPR173 orphans o
aThe receptors are indicated through their gene name. Uniprot name, when different from the gene name, and common synonyms are listed in parentheses. Orphan
receptors are indicated in bold and indicated as ‘o’ in Notes.
cThe Symbol ‘‘N’’ indicates that pairs of receptors of the subgroup do not satisfy max(dN),1 in the Nei-Gojobori counting scheme [64]. The symbol ‘‘S’’ indicates that
pairs of receptors from the subgroup do not satisfy max (dS),3 in the Nei-Gojobori scheme. The symbol ‘‘o’’ indicates that the subgroup has one or more orphan GPCR.
eListed within the category of divergent receptors because only one member is not an orphan receptor.
fGroup derived by the merging of groups 38 and 41.
gContains also the three N-formyl-methionyl peptide receptors listed in subgroup 37.
doi:10.1371/journal.pone.0027813.t004
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We have found that class A GPCR subgroups that are naturally
activated by small molecules possessed strong negative selection in
the key positions. Additionally, the selection pressure at the key
positions is more likely to be stronger than the rest of the TM
positions in small molecule receptors. The existence of strong
negative selection supports coevolution over evolutionary drift as
an explanation for the high mutual information between the key
positions. We suggest that collective substitutions of key residues
under strong selection pressure may have altered function in
GPCRs. It has been shown previously that evolutionary
characteristics such as phylogeny and sequence similarity of AA
residues are a strong predictor of determinants of ligand specificity
[27,28,29].
Under the rules of formal logic, the observation that small
molecule receptors are always under strong negative selection at
key positions allows for the prediction that GPCRs not under
strong negative selection pressure are not naturally activated by
small molecules. Based on our results from Figures 2 and S1, a
threshold of v=0.1 can be established for strong negative
selection (Figures 2 and S1 show that max(vkey<0.05) and
max(vrandom7TM<0.1)). We thus predict that receptor subgroups
with v.0.1 at the key positions do not possess a natural small
molecule ligand. This would include orphan receptors MAS1L,
MRGPRF of group 41, MRGPRX3, MRGPRX4 of 38 and 44,
and TAAR5, TAAR6, TARR8, and TAAR9 of 42. The inclusion
of subgroup 42 may be considered to be surprising because
TAAR1 of the group binds b-phenylethylamine and p-tryamine,
which is a small molecule trace amine. Although this subgroup
exhibits negative selection in conformation of recent studies
involving TAAR orthologs [30,31] it is not strongly negative. This
may imply that even though TAAR1 binds a trace amine, the key
positions may not be vigorously maintaining their functionality.
Positive selection can lead to adaptation of a previous function
[32,33,34,35]. Strong statistical evidence for positive selection was
identified at key position 3.29 of subgroup 38 but not for subgroup
41, both of which are composed of MAS-related GPCRs.
Statistical evidence for positive selection at key position 3.29 was
identified in subgroup 44, with decreased statistical significance
(results not shown). Because subgroup 44 comprises of subgroups
41 (MAS1L, MRGD, MAS, MRGRF) and 38 (MRGX1,
MRGX2, MRGX3, MRGX4), sustained positive selection at
3.29 suggests adaptation specific to subgroup 38. Notably, in the
3D crystal structure of bovine rhodopsin [36], positions 3.29, 2.56
and 2.60 are near neighbors when represented on the resolved
crystal structure of bovine rhodopsin in Figure 4. This suggest that,
if there has been any novel or adaptive function in the interhelical
cavity of MRGX1-type receptors, then it may have evolved via
mutations (substitutions) that occurred in that circumscribed
region of the receptor. Therefore, as a continuation of our novel
bioinformatic approach, we identified an AA position from a
cohort of statistically related AA positions in a protein family
(namely, class A GPCRs) that evolves under strong positive
selective pressure in a subgroup (namely, subgroup 38).
We examined entropy and measures of sequence similarity to
test the hypothesis that strong selection pressure is related to low
variability. Our results showed that even under strong negative
selection pressure, sequence diversity remained. The wide diversity
in selection pressure for receptors associated with the different
classes of natural ligands was not attributable to the size of the
subgroup. Diversity of v values is well documented [37,38,39,40]
and for the different subgroups of GPCRs may be attributed to
differences in the (i) natural ligands they bind, (ii) molecular
mechanism of activation, (iii) phylogeny of the subgroups, and (iv)
ubiquity of expression on cell surfaces [41,42,43].
The inclusion of orthologs would improve the accuracy of our
analysis. We used three overlapping subgroups: 13b (overlapping
with 13), 43 (overlapping with 37) and 44 (overlapping with 38 and
41) to probe how vkey and vrandom7TM changed with subgroup
size. Subgroup 13b contained a pseudogene GPR42. Studies of
class A GPCR orthologs have been previously investigated using
opsins, MAS-related receptors, P2Y receptors and melanocortin
receptors [22,23,44,45,46,47,48,49,50,51]. Amongst the GPCRs
we studied, statistically significant positive selection has been
widely reported for visual opsin receptors (receptors for trichro-
matic vision in old world primates) and subgroup 38 of MAS-
related receptors (receptors for pain and itch). The divergence
among human GPCR subgroups is varied and high polymorphism
may be seen from recent studies, e.g. in the case of human
MRGX1 receptors [52].
Figure 1. The vkey values at key positions of subgroups of class A non-olfactory human GPCRs. Columns 1–10 represent the computed
vkey at the 10 key class A positions listed along the X axis using the Ballesteros-Weinstein index for GPCRs. The color code represents v values ranging
from violet (v,10
23) to red (v,1). GPCRs from forty-five different subgroups (labeled 1–45) are listed in Tables 1, 2, 3 and 4. Subgroups 1–10 are
receptors that are naturally activated by small molecules (Table 1), 11–19 by lipids (Table 2), 20–38 by peptides (Table 3). Subgroups 39–44 are
categorized as divergent and subgroup 45 exclusively contains orphan GPCRs (Table 4).
doi:10.1371/journal.pone.0027813.g001
Table 5. P-value and likelihood ratio (LR) estimates from three PAML strategies for subgroups 38 and 44.
PAML nested
model pairs subgroup 38 subgroup 44
D=ln(LAlt/LNull)=lnLAlt2lnLNull P-value D=ln(LAlt/LNull)=lnLAlt2lnLNull P-value
Test 1 (M2a vs. M1a) 8.90 ,5.0610
24 7.71 ,2.5610
23
Test 2 (M8 vs. M7) 8.94 ,5.0610
24 17.65 ,,5.0610
24
Test 3 (B vs. A) 7.98 ,5.0610
23 31.82 ,,5.0610
24
Result of D and P-value from Tests 1, 2 and 3. LR=2D=2ln (LAlt/LNull)=2(lnLAlt2lnLNull).
doi:10.1371/journal.pone.0027813.t005
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Identification of key positions
An alignment of human non-olfactory class A 7TMs was
obtained from [53]. Using that MSA, we identified a clique of
statistically related MSA positions. These key positions had the
highest collective MI with respect to one another and most other
positions in the MSA [13,14]. The Ballesteros-Weinstein indexing
scheme for GPCRs [24] was used to label all positions of the MSA.
Input data – nucleotide sequence data corresponding to
7TMs
Nucleotide sequence fragments that encoded the GPCR 7TMs
were obtained from NCBI’s nucleotide database [54]. The cDNA
sequence records encoding the entire protein sequence was
extracted using NCBI’s Open Reading Frame online resource
[55]. Entire AA sequence records were obtained from the RefSeq
database [56] and the Uniprot database [57]. The amino acid and
nucleotide sequence fragments from the 7TMs were concatenated.
We used the IUPHAR 7TM receptor database [58,59] as well as a
comprehensive GPCR listing from Gloriam et al. [60] to confirm
our sequence data.
Input data – Phylogenetic tree
We used AA sequence fragments for the 7TMs of class A
GPCRs to reconstruct a nearest neighbor phylogenetic tree.
Program PROTDIST of PHYLIP [61] was used to compute
phylogenetic distance across pairs of concatenated 7TM fragments
using the JTT matrix for AA substitutions [62]. The nearest
neighbor joining method [63] implemented in PHYLIP’s program
NEIGHBOR was used to reconstruct the tree. Subgroups of
GPCRs representing closely related 7TMs were identified from
the phylogenetic tree, using a bootstrap approach. The selection of
subgroup was refined using dN and dS selection criteria described
below. A consensus phylogenetic tree was obtained using the
CONSENSE program of PHYLIP. A list of GPCRs for all
subgroups is shown in Tables 1, 2, 3 and 4.
GPCR subgroups
We analyzed forty-five subgroups, of which forty-two were non-
overlapping and distinct. The number of constituent GPCRs in
respective subgroups ranged from three to ten. Because GPCRs
are highly divergent, we restricted the average maximum dN and
maximum dS estimated from all pairs of receptors within
subgroups unlike in a traditional analysis where subgroups may
Table 6. v for subgroup 38.
7TM MSA position index key
Ballesteros-Weinstein
index
posterior probability
(v.1) NEB v comment
8 1.37 0.562 3.953 -
19 1.48 0.680 4.598 -
49 2.56 0.948 6.065 Positive
50 2.57 0.610 4.226 -
53 2.60 0.947 6.062 Positive
57 2.64 0.595 4.147 -
61 3.22 0.514 3.690 -
62 3.23 0.824 5.390 -
64 3.25 0.794 5.228 -
65 3.26 0.533 3.796 -
68 X 3.29 0.998** 6.338 Positive
69 3.30 0.531 3.783 -
71 X 3.32 0.001 0.367 Negative
72 X 3.33 0.094 1.351 -
77 3.38 0.776 5.126 -
110 4.56 0.930 5.967 -
114 X 4.60 0.010 0.556 Negative
117 X 5.35 0.253 2.213 -
121 X 5.39 0.001 0.336 Negative
124 X 5.42 0.215 2.044 -
168 X 6.55 0.831 5.429 -
171 X 7.35 0.127 1.509 -
175 X 7.39 0.222 2.087 -
179 7.43 0.574 4.022 -
Model M8 NEB values obtained from subgroup 43. Key position 3.29 is under positive selection (** denotes statistically significant posterior probability for v.1). Two
non-key positions, 2.56 and 2.60, have posterior probability exceeding 90% for positive selection. All positions with posterior probability for v.1which exceed 0.5 are
represented. Results of v from the 10 key positions are also included. Key positions identified in Reference [13,14] are indicated by X. Statistics of the 3 positions under
positive selection are represented in bold italics.
doi:10.1371/journal.pone.0027813.t006
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tree. We used the counting scheme of Nei-Gojobori to estimate the
average dN and dS from pairs of sequences [64]. We investigated
subgroups where the maximum average dN of all pair-wise
comparisons within the subgroup did not exceed 1. If the
condition of max(dN),1 was not met, then the out group taxa
was removed, and the subgroup reduced. There was no a priori
scheme to identify subgroups to achieve the max(dN) and max(dS)
conditions. To study the measurement uncertainties due to sample
size, we analyzed subgroups having progressively larger numbers
of closely related receptors. The subgroups in which it exceeded 1
were indicated by ‘‘N’’ in Tables 1, 2, 3 and 4 and were not
included in Figure S4, Figure S6 and Figure S8. We found that
max(dN),1 selection resulted in max(dS),3 for forty of forty-five
subgroups. Subgroups listed in Tables 1, 2, 3 and 4 and denoted
by ‘‘S’’ did not meet max(dS),3. The dN and dS obtained after
maximum likelihood computation was more conservative com-
pared to that obtained via the Nei-Gojobori counting method
(results not shown).
Estimation of v at AA positions across 7TMs
PAML version 4.2b [65] was used to model the evolution of the
7TM nucleotide sequences using a state space of possible codons
from the genetic code. The program simulated the molecular
evolution of the concatenated 7TM fragments independently, for
each subgroup. Four independent strategies from PAML were
used to estimate v. Two mathematical models were tested for
statistical tenability in each strategy. The constraints and
assumptions for estimating v were accommodated differently in
the models. In the first strategy, model M2a accommodated
positions under negative selection via v=v0 (v0,1), a free
parameter determined from data, that was common for most 7TM
positions. In addition, to represent neutral evolution, a portion of
the remaining 7TM positions were constrained to v1=1. Lastly,
with another free parameter, the same model also accommodated
representation of positive selection for the remaining fraction of
positions (v2.1). In contrast, model M1a was a special case of
M2a, in which it excluded positive selection. Because v for an AA
position under near-neutral evolution was also constrained to
unity, this was the most conservative of the three strategies. Test 1
compares M1a vs. M2a.
In the second strategy the spectrum of v values from MSA
positions was represented by a beta function (with two free
parameters p and q). Model M8 represented the spectrum of v
across all MSA positions with ten discrete vi categories to
represent the beta function (for vi#1, i=0,1,2…,9). An additional
eleventh category v10 accounted for a small fraction of positions
under positive selection. In model M7, there was no provision for
such positive selection (p10=0, therefore v10 was absent). Test 2
compares M7 vs. M8.
In a third strategy, we used Yang and Swanson’s ‘‘fixed sites’’
models A and B [25]. The null model (model A) hypothesized that
there was no statistically distinct selection pressure among the
MSA positions. We used the simplest alternate model (model B),
from the suite of ‘‘fixed sites’’ models, which hypothesized that the
average evolutionary selection pressure from cohort of key MSA
positions was statistically distinct with respect to the other MSA
positions.
In all the three strategies, which we refer to as Tests 1–3 in
Table S1, a maximum likelihood ratio test was used to determine
the tenable model from competing nested paired models. The goal
of both models was to represent the observed evolutionary data –
the MSA of nucleotide 7TM sequences and the phylogenetic tree
from the relevant subgroup. In each strategy, the maximum
Figure 2. The average v of key positions (,vkey.) contrasted
with average v of randomly selected 7TM positions (,vran-
dom7TM.). Results of selection pressure, from PAML’s model M7, for
subgroups 1–45 and listed in Tables 1, 2, 3 and 4 are shown above.
Results from model M8 were obtained for subgroups 38 and 44. Filled
triangle represents ,vkey. while open triangle represents the average
of the average from random cohorts (from the ,vrandom7TM.
distribution). The error bar represents two standard deviations
(2srandom7TM) or the 95% confidence interval from vrandom7TM
distribution.
doi:10.1371/journal.pone.0027813.g002
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compared with that obtained from an alternate model MAlt (which
had additional free parameters compared to the null model).
In a fourth strategy, which we called Test 4, model M3 was
compared to model M0 for all subgroups. The alternative model
demonstrated the heterogeneity of v values across the 7TMs and
the null model was representative of their common v value. Test 4
is not specific for inferring positive selection and all results are
shown in Table S2.
Chemical class of the natural ligands associated with
class A GPCRs
Subgroups were classified into three categories in terms of their
natural ligands: 1) small molecules (including biogenic amines,
nucleosides and nucleotides), 2) lipids and 3) peptides. If subgroups
did not exclusively bind the same chemical class of natural ligand
or if they had more than two orphan receptors, then we
categorized them as divergent. If subgroups exclusively contained
orphan receptors then they were categorized as orphan.
Computing average v from randomly selected 7TM AA
positions
To compare ,vkey. with randomly selected 7TM positions,
two hundred cohorts of AA positions were simulated. The average
v from each of the cohort of ten randomly selected 7TM positions
was computed – this was denoted as ,vrandom7TM.. The average
of the two hundred independent cohorts was computed from the
distribution of ,vrandom7TM..
Computing AA diversity at key positions
Shannon entropy was first used to estimate the diversity in AA
composition at key positions across all subgroups. The Shannon
entropy at MSA position X, with AA residues x, was defined as
H(X)~
X
p(x)log2p(x):
Here the summation is over all rows r of the MSA, p(x) was the
probability of having residue x at position X, and the summation is
over all AA residues.
A variety of strategies exist to quantify sequence similarity [66].
We used two independent approaches to estimate the similarity of
key AA residues using all subgroups. In the first method, sequence
similarity was estimated with the BLOSUM substitution matrix
[26]. Consider S to be the number of concatenated 7TM
fragments in a subgroup. The AA similarity (and dissimilarity)
among MSA positions of 7TM fragments due to substitutions
among the S different paralogs of the subgroup was determined.
We used BLOSUM80 substitution matrix to evaluate sequence
similarity among the residues at key positions of the MSA. For a
given key position, the average score of the key AA residues
substituting with each other within the subgroup, we used the
definition of Karlin and Brocchieri [67], given by the equation
CKarlin(X)~
2
S(S{1)
X S
r
X S
s
M(cr(x)cs(y))~
2
S(S{1)
X S
r
X S
s
Mrs(x,y),
where cr(x) is the AA at MSA position (or column) X in the sth
fragment, and Mrs(x,y) scores for substitution between AA x and
AA y. This similarity score Mrs(x,y), for the defined (r,s) pairs of AAs
in the r
th and s
th sequence fragment, is defined as
Mrs(x,y)~
mrs(x,y)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mrr(x,x)mss(y,y)
p ,
where mrs(x,y) is the BLOSUM80 [26] matrix element correspond-
ing to substitution from AA x in the r
th row to AA y in the s
th row of
the alignment (or vice versa). We defined the BLOSUM similarity
score for a given key position X as BLO_80key=C Karlin(X), and the
average similarity score of all key positions ,BLO_80key. was
averaged over the ten key positions.
In another approach, another estimate for dissimilarity was
obtained using residues from MSA columns at key positions. To
represent a distance measure, the average percentage of accepted
mutation using program PROTDIST from PHYLIP software [61]
was obtained for all key positions in subgroups. That measure was
denoted as Dkey. The quantity 2log10(Dkey) was computed to
Figure 3. Graph showing the trends in ,vkey./,vrandom7TM. vs. ,v.. Subgroups with pair-wise max(dN),1 are represented in these
panels. Subgroups 38 and 44 are excluded to avoid bias due to positive selection. a) Plot of ,vkey./,vrandom7TM. vs. ,vkey.. b) Plot of ,vkey./
,vrandom7TM. vs. ,vrandom7TM..
doi:10.1371/journal.pone.0027813.g003
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Supporting Information
Figure S1 The average v from key positions (,vkey.)
contrasted with average v from randomly selected 7TM
positions (,vrandom7TM.). Results of selection pressure, from
PAML’s model M7 vs. M8, for subgroups 1–45, as listed in
Tables 1, 2, 3 and 4 of manuscript, are shown. The v values on
the Y axis are represented in a linear scale (panel A) and
logarithmic scale (panel B – Figure 2 in manuscript). Subgroups
from 1–10 (shown in Table 1) are receptors naturally activated by
small molecules, 11–19 (shown in Table 2) by lipids and 20–38
(shown in Table 3) by peptides. Subgroups 39–44 (shown in
Table 4) are divergent. Subgroup 45 exclusively contains orphan
GPCRs. Filled (red colored) triangle represents ,vkey. while
open triangle represents the average from random cohorts (from
,vrandom7TM. distribution). The error bar represents two
standard deviations (2srandom7TM) or the limits of 95% confidence
interval from vrandom7TM distribution.
(TIFF)
Figure S2 Graph of ,vkey. vs. ,vrandom7TM.. Trend
from ,vkey. vs. ,vrandom7TM. is shown using a logarithmic
scale. Graph excludes subgroups labeled as ‘‘N’’ in Tables 1, 2, 3
and 4 and excludes subgroups 38 and 44.
(TIFF)
Figure S3 Shannon entropy (H) for key positions across
GPCR subgroups.
(TIFF)
Figure 4. Notable positions of the MRGX1-type receptors visualized in the crystal structure of bovine rhodopsin. Positions 2.56, and
2.60 and 3.29 are under positive selection pressure and shown in white 23.29 is a key position, while 2.56 and 2.60 are not. Residues at two key
positions, 3.32 and Val 204 5.39 are under negative selection pressure and shown in green. Residues at remaining 7 key positions are not under
strong selective pressure are shown in yellow. Those positions are 3.33, 4.60, 5.35, 5.42, 6.55, 7.35 and 7.39. The figure is relative to the structure of
bovine rhodopsin published by Schertler and coworkers (PDB ID: 1GZM) [70]. The notable positions are represented through spheres centered on the
Ca atoms of the corresponding rhodopsin residues. The backbone of the receptor is schematically represented as a ribbon, colored with continuum
spectrum that transitions from red to purple moving from the N-terminus to the C-terminus (TM1: dark orange; TM2: light orange; TM3: yellow; TM4:
yellow/green; TM5: green; TM6: cyan; TM7: blue/purple).
doi:10.1371/journal.pone.0027813.g004
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tion pressure for key positions across subgroups.
Average scores from Figure S3 are plotted along the Y axis.
Average evolutionary selection pressure from Figure 1 is
represented using a logarithmic scale on the X axis. Subgroups
not labeled ‘‘N’’ from Tables 1, 2, 3 and 4 (having pair-wise
max(dN),1) are represented here.
(TIFF)
Figure S5 Similarity scores for key positions across
GPCR subgroups. Similarity scores (,BLO_80key.) in sub-
group MSA defined by Karlin and Brocchieri, as in Reference 67,
(described in Materials and Methods) generated using BLO-
SUM80 matrix.
(TIFF)
Figure S6 Average similarity score ,BLO_80key. vs.
average selection pressure for key positions across
subgroups. Average scores from Figure S5 are plotted along
the Y axis. Average evolutionary selection pressure from Figure 1
is represented using a logarithmic scale on the X axis. Subgroups
not labeled ‘‘N’’ from Tables 1, 2, 3 and 4 (having pair-wise
max(dN),1) are represented here.
(TIFF)
Figure S7 Inverse protdist distance measure
(,2log10Dkey.) for key positions across GPCR sub-
groups. Plot showing the logarithm of inverse protdist distance
(D) at key positions from GPCR subgroups.
(TIFF)
Figure S8 Average inverse protdist distance vs. average
selection pressure for key positions across subgroups.
The Y-axis represents ,2log10Dkey. from Figure S7. Average
evolutionary selection pressure is represented using a logarithmic
scale on the X axis. Subgroups not labeled ‘‘N’’ from Tables 1, 2, 3
and 4 (having pair-wise max(dN),1) are represented here.
(TIFF)
Table S1 Tenable PAML models representing molecu-
lar evolution of 7TMs of class A non-olfactory human
GPCR subgroups. PAML’s tenable models that represent
molecular evolution of their 7TMs are illustrated across GPCR
subgroups. Results from two ‘‘random sites models’’ M2a vs.M1a
(Test 1), M8 vs. M7 (Test 2) and that from Yang-Swanson ‘‘fixed
sites’’ model A vs. model B (Test 3) are presented in columns 5–7.
Tenable alternative models are represented ‘‘A’’ and tenable null
models labeled ‘‘-’’. Bold font in column 3 connotes orphan
GPCR. Bold and italics font in columns 5–7 connote inference of
positive selection.
(DOC)
Table S2 Tenable PAML models representing molecu-
lar evolution of 7TMs of class A non-olfactory human
GPCR subgroups. PAML’s tenable models that represent
molecular evolution of their 7TMs are illustrated across GPCR
subgroups. Results from ‘‘random sites models’’ M3 vs. M0 (Test
1) are presented. Tenable alternative models are represented ‘‘A’’
and tenable null models labeled ‘‘-’’. Bold font in column 3
connotes orphan GPCR. Bold and italics font in columns 5
connotes inference of significant positive selection.
(DOC)
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